Blood Volume Analyzer Industry - Regional Synopsis
North America Market Forecast
North America industry is likely to account for largest revenue share of 42% by 2037. Since, the region has well-established infrastructure, health facilities, and skilled labor, which makes patients easily access highly advanced treatment techniques. In addition to this, increasing medical expenses are adding fuel to the blood volume analyzer market.
As per Health System Tracker, 20 million U.S adults have medical debt of USD 1,000 and still, some other medical debt figures cannot be accurately estimated. Moreover, medical expense is a persistent problem for many individuals and that’s why they choose cost-efficient medical services and products.
Further, in Canada heart diseases rank second in the list of most prevailing diseases and chronic disease management is becoming a priority task for the government. According to data from Canadian Chronic Disease Surveillance, around 2.6 million adults aged 20 or more are diagnosed with heart disease. This high number of heart disease cases in the region are predicted to raise the blood volume analyser market demand.
Asia Pacific Market Analysis
Asia Pacific region in blood volume analyzer market is set to showcase over 7% growth rate between 2024 and 2037 due to the increased cases of cancer and other blood disorders. In China, nearly 5 million new cases have been reported in 2022.
Cancer is reportedly a leading cause of death in Japan and is rapidly increasing due to the aging of the population. The most common types of cancers are related to the stomach, prostates, female breast, etc. According to the National Cancer Centre of Japan, nearly 1 million new cases of cancer have been witnessed in 2022.
Further, in Japan the market is witnessing growth as a result of the growing elderly population. This is because old aged people are more prone to diseases that may raise the need for blood volume analyzers.
